Kainos Laboratories Inc. (4556) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kainos Laboratories Inc. (4556:JPX), powered by AI.

Current Price
¥2,268
P/E Ratio
14.9
Market Cap
9.6B
Sector
Healthcare
What is the Kainos Laboratories Inc. stock price forecast?

Kainos Laboratories Inc. is currently trading at ¥2,268. View real-time AI analysis on Alpha Lenz.

What is Kainos Laboratories Inc. insider trading activity?

View the latest insider trading data for Kainos Laboratories Inc. on Alpha Lenz.

What is Kainos Laboratories Inc.'s P/E ratio?

Kainos Laboratories Inc.'s P/E ratio is 14.9.

Kainos Laboratories Inc.

JPX · 4556
¥2,268+0(+0.00%)Market closedJPX regular session 09:00–15:00 JST
Ask about Kainos Laboratories Inc.'s future dividend policy...
Alpha Chat Insight

Kainos Laboratories Inc. trades at a P/E of 14.9 (undervalued) with solid ROE of 9.8%.

Ask for details

Company Overview

Kainos Laboratories Inc. is a biotechnology company engaged in the research, development, and commercialization of innovative diagnostic solutions. The primary function of Kainos Laboratories is to enhance healthcare outcomes through advanced diagnostic tools, which are pivotal in early detection and disease management. Specializing in clinical diagnostics and laboratory instruments, the company serves a diverse array of sectors, including healthcare institutions, research facilities, and pharmaceutical companies. With a focus on delivering precise and reliable testing equipment, Kainos Laboratories supports both private and public healthcare systems, contributing significantly to the efficacy of health monitoring and disease prevention strategies. The company's technological advancements and commitment to quality have established it as a reputable entity within the biotech industry, highlighting its role in improving global healthcare standards.

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees133

Company Statistics

FY 2025

Profile

¥9,561,116,880Market Cap
¥5,305,568,000Revenue
0.00Shares Out
133Employees

Margins

50.41%Gross
17.68%EBITDA
15.52%Operating
15.59%Pre-Tax
12.08%Net

Valuation

14.92P/E
1.41P/B
1.80EV/Sales
7.24EV/EBITDA
15.23P/FCF

Growth (CAGR)

4.76%Rev 3Yr
2.85%Rev 5Yr
3.27%Op Inc 3Yr
6.23%Op Inc 5Yr
7.76%Net Inc 3Yr
9.97%Net Inc 5Yr

Returns

7.38%ROA
9.83%ROE
9.60%ROIC

Financial Health

¥3,396,322,000Cash & Cash Equivalents
¥-1,386,355,000Net Debt
29.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kainos Laboratories Inc. (ticker: 4556) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 133 employees. Market cap is $9.6B.

The current price is 2,268 with a P/E ratio of 14.92x and P/B of 1.41x.

ROE is 9.83% and operating margin is 15.52%. Annual revenue is $5.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kainos Laboratories Inc. (4556) Stock Forecast 2026 ¥2,268 — Price, Financials & Analyst Targets | Alpha Lenz